← All trials
NCT00671060
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Dec 1, 2011
- Completion date
- Dec 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 153
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Gynuity Health ProjectsLead sponsor
- Gynuity Health ProjectsOverall official - principal investigator
- Stanford UniversityCollaborator
- University of FloridaCollaborator
- Boston UniversityCollaborator
- Thomas Jefferson UniversityCollaborator
- Huong Vuong HospitalCollaborator
- Yeshiva UniversityCollaborator
- University of Illinois at ChicagoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.